Loteprednol Etabonate 0.25% for Prevention of Cornea Transplant Rejection

Clinical trial NCT05136443 · COMPLETED

Trial details

NCT number: NCT05136443
Sponsor: Price Vision Group
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Corneal Endothelial Dystrophy Corneal Edema

Start date: 2021-11-23
Primary completion: 2023-09-05
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.